Global Markets for Research Antibodies to Reach $3.0B by 2022

January 16, 2018

WELLESLEY, Mass., Jan 16, 2018 – Dramatic change in leading antibody manufacturing technologies is spurring growth in research antibodies, which have the potential to comprise a $3.0 billion global market by 2022. In a new report by BCC Research, the industry’s prospects and market trends are studied by research applications and by regions.

All regional research antibody markets will experience growth at different rates. Due to strong R&D investment, the Asia-Pacific market will have the most rapid 5-year growth rate (7.0%). The U.S. market—which held approximately 40% of the global research antibody market in 2016—will continue to be affected by cuts in research funding and will grow by an estimated 3.4%. Over the next 5 years, market growth in research antibodies is expected to be more focused on “content” than on “volume,” according to the report Global Markets for Research Antibodies.

Various sectors constitute key revenue streams for the research antibody market, e.g., customer type. Application-based market segments include enzyme-linked immunosorbent assay, western blotting, immunohistochemistry, immunofluorescent staining and flow cytometry.

Drivers of Market Growth:  

  • Significantly enhanced antibody validation that will improve and potentially increase antibody uses, a high diversity of product attributes, and a strongly competitive landscape.
  • New discoveries in biological sciences, increased government funding, and antibody-based drug discovery and development, including the success of antibody-drug conjugates.
  • Need for further human genomic and proteomic research in areas including stem cell research, genome editing, exosome biology, epigenetics, neuroscience, and cancer research.

“Market trends and growth opportunities are shaped by customer needs and purchasing factors from different types of end users and decision makers,” said Mike Fan, BCC Research analyst and author of these report. “Also critical are factors affecting the strategies of antibody companies, effects of research funding, third-party quality evaluation systems, and merger and acquisition activities.”

Increasing Use of Custom Services

Custom services have become an important part of the research antibody market. Such services include custom production of polyclonal or monoclonal antibodies, antibody conjugation, labeling and antigen preparation. In particular, new antibody production technologies (e.g., the use of DNA as an antigen, recombinant antibody technology and rabbit monoclonal antibody technology) are becoming major drivers of the research antibody services market.

Editors/reporters requesting analyst interviews should contact

Global Markets for Research Antibodies( BIO141B )
Publish Date: Dec 2017    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.